↓ Skip to main content

Patients’ intention to consume prescribed and non‐prescribed medicines: A study based on the theory of planned behaviour in selected European countries

Overview of attention for article published in Journal of Clinical Pharmacy & Therapeutics, August 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

news
2 news outlets

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
77 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Patients’ intention to consume prescribed and non‐prescribed medicines: A study based on the theory of planned behaviour in selected European countries
Published in
Journal of Clinical Pharmacy & Therapeutics, August 2017
DOI 10.1111/jcpt.12601
Pubmed ID
Authors

A. Kamekis, A. Bertsias, J. Moschandreas, E. Petelos, M. Papadakaki, V. Tsiantou, A. Saridaki, E. K. Symvoulakis, K. Souliotis, N. Papadakis, T. Faresjö, A. Faresjö, L. Martinez, D. Agius, Y. Uncu, T. Sengezer, G. Samoutis, J. Vlcek, A. Abasaeed, B. Merkouris, C. Lionis

Abstract

Polypharmacy has a significant impact on patients' health with overall expenditure on over-the-counter (OTC) medicines representing a substantial burden in terms of cost of treatment. The aim of this study, which was conducted within the framework of a European Project funded by the European Union under the Seventh Framework Programme and was entitled OTC-SOCIOMED, was to report on possible determinants of patient behaviour regarding the consumption of medicines, and particularly OTCs, in the context of primary care. A multicentre, cross-sectional study was designed and implemented in well-defined primary healthcare settings in Cyprus, the Czech Republic, France, Greece, Malta and Turkey. Patients completed a questionnaire constructed on the basis of the theory of planned behaviour (TPB), which was administered via face-to-face interviews. The percentage of patients who had consumed prescribed medicines over a 6-month period was consistently high, ranging from 79% in the Czech Republic and 82% in Turkey to 97% in Malta and 100% in Cyprus. Reported non-prescribed medicine consumption ranged from 33% in Turkey to 92% in the Czech Republic and 97% in Cyprus. TPB behavioural antecedents explained 43% of the variability of patients' intention to consume medicines in Malta and 24% in Greece, but only 3% in Turkey. Subjective norm was a significant predictor of the intention to consume medicines in all three countries (Greece, Malta and Turkey), whereas attitude towards consumption was a significant predictor of the expectation to consume medicines, if needed. This study shows that parameters such as patients' beliefs and influence from family and friends could be determining factors in explaining the high rates of medicine consumption. Factors that affect patients' behavioural intention towards medicine consumption may assist in the formulation of evidence-based policy proposals and inform initiatives and interventions aimed at increasing the appropriate use of medicines.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 77 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 13%
Student > Master 9 12%
Researcher 8 10%
Student > Postgraduate 7 9%
Student > Ph. D. Student 6 8%
Other 13 17%
Unknown 24 31%
Readers by discipline Count As %
Social Sciences 11 14%
Medicine and Dentistry 9 12%
Nursing and Health Professions 8 10%
Business, Management and Accounting 5 6%
Psychology 5 6%
Other 15 19%
Unknown 24 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 August 2017.
All research outputs
#2,486,524
of 25,382,440 outputs
Outputs from Journal of Clinical Pharmacy & Therapeutics
#160
of 1,637 outputs
Outputs of similar age
#45,711
of 327,377 outputs
Outputs of similar age from Journal of Clinical Pharmacy & Therapeutics
#8
of 27 outputs
Altmetric has tracked 25,382,440 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,637 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 327,377 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.